Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has assigned three Venezuelan patents to its wholly-owned subsidiary, Inversiones Long 33, C.A. The patents, previously held by CEO Dr. Kevin Rodan Levy, cover technologies dubbed CardioAI, PulmoAI, and NeuroAI, which are designed for data-driven healthcare analytics, predictive modeling, and clinical decision-support applications. This move is part of the company's strategy to align its intellectual property with its operating structure and position the subsidiary as the primary development and commercialization vehicle for its technology platform in the region.
The company believes that consolidating IP at the operating level enhances strategic flexibility, supports regulatory alignment, and may facilitate future partnerships, licensing opportunities, and regional expansion initiatives. Additionally, Catalyst Crew intends to pursue expanded IP protection for its technologies in other jurisdictions worldwide to support long-term platform development and potential international deployment.
Dr. Kevin Rodan Levy stated: "Aligning our intellectual property within our operating structure is an important step as we continue building our platform. Establishing a clear foundation around our core technologies allows us to move forward with development, partnerships, and, where appropriate, broader intellectual property protection strategies across additional markets."
The company continues to advance its digital health and AI platform, focusing on scalable healthcare solutions including telehealth infrastructure, remote patient monitoring, and advanced healthcare analytics. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies Corp. is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth, remote monitoring, data analytics, and integrated digital care platforms. Through technology development, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform to address the growing demand for modernized healthcare delivery systems in emerging markets.
